modelEtodolac

Diagram of Etodolac

Extends from Pharmacolibrary.Drugs.ATC.M.M01AB08.

Information

name:Etodolac
ATC code:M01AB08
route:oral
compartments:2
dosage:200mg
volume of distribution:10.4L
clearance:49ml/min
other parameters in model implementation

Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) used for the management of mild to moderate pain, osteoarthritis, and rheumatoid arthritis. It is commonly administered orally and is approved for medical use in many countries.

Pharmacokinetics

Pharmacokinetic parameters reported for healthy adult volunteers after a single 200 mg oral dose.

References

  1. Boni, J, et al., & Cooper, S (1999). Pharmacokinetic and pharmacodynamic action of etodolac in patients after oral surgery. Journal of clinical pharmacology 39(7) 729–737. DOI:10.1177/00912709922008254 PUBMED:https://pubmed.ncbi.nlm.nih.gov/10392328

  2. Brater, DC, & Lasseter, KC (1989). Profile of etodolac: pharmacokinetic evaluation in special populations. Clinical rheumatology 8 Suppl 1 25–35. DOI:10.1007/BF02214107 PUBMED:https://pubmed.ncbi.nlm.nih.gov/2525981

  3. Benet, LZ (1994). Pharmacokinetic profile of etodolac in special populations. European journal of rheumatology and inflammation 14(1) 15–18. PUBMED:https://pubmed.ncbi.nlm.nih.gov/7744123

Parameters

TypeNameDefaultDescription
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.9Volume of distribution (L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)0.8bioavailiability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)20clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1000administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Pharmacolibrary.Types.VolumeVdp (from PK_2C)VdpPerKg*weightVolume of distribution (m3)
Modelica.Units.SI.SpecificVolumeVdpPerKg (from PK_2C)0.9Volume of distribution peripheral(l/kg)
Pharmacolibrary.Types.Clearancek12 (from PK_2C)1intercompartmental C-P clearance
Pharmacolibrary.Types.Clearancek21 (from PK_2C)1intercompartmental P-C clearance
Pharmacolibrary.Types.TransferRateka (from PK_2C_enteral)0.016666666666666666first order absorption rate
Modelica.Units.SI.TimeTlag (from PK_2C_enteral)600delay between oral administration and absorption (default 10min)

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)
Interfaces.ConcentrationPort_bperipheralCPort (from PK_2C)
Pharmacolibrary.Types.ConcentrationOutputC_peripheral1 (from PK_2C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)elimination half-life
Pharmacolibrary.Pharmacokinetic.TransferFirstOrderNonSymtransfer (from PK_2C)
Pharmacolibrary.Pharmacokinetic.NoPerfusedTissueCompartmentperipheral (from PK_2C)

Revisions

  • 06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)